Protalix and Chiesi Report Positive Results From Fabry Disease Trial Post author:PacConAdmin Post published:March 21, 2022 Post category:Drug Industry Daily The rare inherited condition Fabry Disease (FD) may soon have a new treatment. Source: Drug Industry Daily You Might Also Like EMA’s PRAC Revises Methods for Measuring Pharmacovigilance Impacts December 1, 2017 FDA Targets Infar over Testing, Records, Sanitation March 13, 2017 AstraZeneca Vaccine Results Likely By Christmas, With Early Efficacy Findings in Weeks November 19, 2020
AstraZeneca Vaccine Results Likely By Christmas, With Early Efficacy Findings in Weeks November 19, 2020